Viewing Study NCT00419250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2025-12-28 @ 8:49 PM
Study NCT ID: NCT00419250
Status: COMPLETED
Last Update Posted: 2019-11-08
First Post: 2007-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Leukemia, B-Cell, Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsed View
None refractory View
None fludarabine View
None Revlimid View
None lenalidomide View
None CLL View
None B-cell CLL View
None CC-5013 View
None Chronic Lymphocytic Leukemia View